These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 12011538)

  • 1. Bactericidal effect of combinations of antibiotic and antineoplastic agents against Staphylococcus aureus and Escherichia coli.
    Nyhlén A; Ljungberg B; Nilsson-Ehle I; Odenholt I
    Chemotherapy; 2002 May; 48(2):71-7. PubMed ID: 12011538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bactericidal effect of combinations of cephalosporins with tobramycin on clinical isolates of Escherichia coli, Klebsiella and Staphylococcus aureus.
    Wagenvoort JH; Brus-Weijer L; Michel MF
    Arzneimittelforschung; 1986 Sep; 36(9):1301-2. PubMed ID: 3539124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro synergy of cefamandole-tobramycin combinations.
    Valenti AJ; Siniscalchi AJ; Andriole VT
    Yale J Biol Med; 1977; 50(2):177-82. PubMed ID: 331694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sulfur hexafluoride gas on antibacterial activity of antibiotics in vitro against agents causing endophthalmitis.
    Yanyali A; Cetin S; Talu H; Vahaboglu H
    Ophthalmologica; 2001; 215(6):439-43. PubMed ID: 11741112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergism and postantibiotic effect of tobramycin and Melaleuca alternifolia (tea tree) oil against Staphylococcus aureus and Escherichia coli.
    D'Arrigo M; Ginestra G; Mandalari G; Furneri PM; Bisignano G
    Phytomedicine; 2010 Apr; 17(5):317-22. PubMed ID: 19699074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postantibiotic effect of meropenem and ciprofloxacin in the presence of 5-fluorouracil.
    Nyhlén A; Ljungberg B; Nilsson-Ehle I; Odenholt I
    Chemotherapy; 2002 Sep; 48(4):182-8. PubMed ID: 12218265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meropenem-induced alteration of the susceptibility of Escherichia coli and Staphylococcus aureus to the bactericidal activity of human polymorphonuclear leucocytes.
    Herrera-Insúa I; Pérez P; Martínez P; Gómez-Lus ML; Prieto J
    J Antimicrob Chemother; 1997 Feb; 39(2):223-8. PubMed ID: 9069543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basis for nebulized antibiotics: droplet characterization and in vitro antimicrobial activity versus Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa.
    Todisco T; Eslami A; Baglioni S; Sposini T; Tascini C; Sommer E; Knoch M
    J Aerosol Med; 2000; 13(1):11-6. PubMed ID: 10947319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergism between tobramycin and ceftazidime against a resistant Pseudomonas aeruginosa strain, tested in an in vitro pharmacokinetic model.
    den Hollander JG; Horrevorts AM; van Goor ML; Verbrugh HA; Mouton JW
    Antimicrob Agents Chemother; 1997 Jan; 41(1):95-100. PubMed ID: 8980762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic-induced release of endotoxin: in-vitro comparison of meropenem and other antibiotics.
    Trautmann M; Zick R; Rukavina T; Cross AS; Marre R
    J Antimicrob Chemother; 1998 Feb; 41(2):163-9. PubMed ID: 9533457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory findings of tobramycin and their relation to clinical response.
    McAllister TA; Tait SC
    J Infect Dis; 1976 Aug; 134 Suppl():S20-7. PubMed ID: 823277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of combinations of ceftazidime, imipenem and pefloxacin against Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa.
    El-Sukhon SN; Faiza Boukhatem Z
    Int J Antimicrob Agents; 2003 Dec; 22(6):613-7. PubMed ID: 14659660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
    Petit JC; Richard G; Burghoffer B; Daguet GL
    Pathol Biol (Paris); 1982 Jun; 30(6):426-31. PubMed ID: 6810286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Different Peritoneal Dialysis Fluids on the In Vitro Activity of Cefepime, Ciprofloxacin, Ertapenem, Meropenem and Tobramycin Against Escherichia Coli.
    Kussmann M; Schuster L; Wrenger S; Pichler P; Reznicek G; Burgmann H; Poeppl W; Zeitlinger M; Wiesholzer M
    Perit Dial Int; 2016 11-12; 36(6):662-668. PubMed ID: 27680756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of ceftazidime in combination with other antibiotics.
    Simon C; Littschwager G
    Infection; 1985; 13(4):184-9. PubMed ID: 3930407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of novel antipseudomonal drugs using the serum bactericidal activity test.
    Braveny I; Machka K; Milatovic D
    Eur J Clin Microbiol; 1986 Feb; 5(1):119-23. PubMed ID: 3084241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro bactericidal activity of cefepime and cefpirome against clinical isolates at Karachi.
    Arsalan A; Naqvi SB; Ali SA; Ahmed S; Shakeel O
    Pak J Pharm Sci; 2015 May; 28(3):841-7. PubMed ID: 26004702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum bactericidal activity of piperacillin/tazobactam against Staphylococcus aureus, piperacillin-susceptible and piperacillin-resistant Escherichia coli and Pseudomonas aeruginosa.
    Lemmen SW; Zolldann D; Klik S; Lütticken R; Kümmerer K; Häfner H
    Chemotherapy; 2004 Apr; 50(1):27-30. PubMed ID: 15084802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bactericidal Effect of Tomatidine-Tobramycin Combination against Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa Is Enhanced by Interspecific Small-Molecule Interactions.
    Boulanger S; Mitchell G; Bouarab K; Marsault É; Cantin A; Frost EH; Déziel E; Malouin F
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7458-64. PubMed ID: 26392496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.
    Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A
    Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.